Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

Cited by (687)

Items 101–200 of 687

1. Nucleic acids: function and potential for abiogenesis
   Falk Wachowius, James Attwater, Philipp Holliger · 2017 · Quarterly Reviews of Biophysics
2. Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development
   Shalini Andersson, Madeleine Antonsson, Marie Elebring, Rasmus Jansson‐Löfmark, Lars O. G. Weidolf · 2018 · Drug Discovery Today
3. Therapeutic RNA Delivery for COVID and Other Diseases
   Curtis N. Dobrowolski, Kalina Paunovska, Marine Z. C. Hatit, Melissa P. Lokugamage, James E. Dahlman · 2021 · Advanced Healthcare Materials
4. Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver
   Colton M. Miller, Michael Tanowitz, Aaron Joseph Donner, Thazha P. Prakash, Eric E. Swayze, Edward N. Harris, Punit P. Seth · 2018 · Nucleic Acid Therapeutics
5. Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches
   Ricardo Oliveira, Eva Pinho, Ana Luísa Sousa, Jeffrey J. DeStefano, Nuno F. Azevedo, Carina Almeida · 2021 · Trends in biotechnology
6. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies
   Saeed Anwar, Farin Mir, Toshifumi Yokota · 2023 · Pharmaceutics
7. Advances and prospects of RNA delivery nanoplatforms for cancer therapy
   Mohamed S. Attia, Gregor Stefan Kijanka, Nam‐Trung Nguyen, Jun Zhang, Hongjie An · 2024 · Acta Pharmaceutica Sinica B
8. Strategies to use microRNAs as therapeutic targets
   Jan Krützfeldt · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
9. OligoTRAFTACs: A generalizable method for transcription factor degradation
   Kusal T. G. Samarasinghe, Elvira An, Miriam A. Genuth, Ling Chu, Scott A. Holley, Craig M. Crews · 2022 · RSC Chemical Biology
10. Ongoing Clinical Trials of Nonviral siRNA Therapeutics
    Eshan A. Narasipura, Rachel VanKeulen‐Miller, Yutian Ma, Owen S. Fenton · 2023 · Bioconjugate Chemistry
11. Synthesis and Characterization of Thiophosphoramidate Morpholino Oligonucleotides and Chimeras
    Heera K. Langner, Katarzyna Jastrzębska, Marvin H. Caruthers · 2020 · Journal of the American Chemical Society
12. Therapeutic RNA-silencing oligonucleotides in metabolic diseases
    Goga, Algera, Stoffel, Markus · 2022 · Nature Reviews Drug Discovery
13. Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
    Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, Chantal M. Ferguson, Ellen Sapp, Hassan H. Fakih, Qi Tang, Nozomi Yamada, Raymond C. Furgal et al. · 2024 · Nature Biotechnology
14. The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules
    Wenzhan Yang, Prajakta Gadgil, Venkata Ramanan Krishnamurthy, Margaret S. Landis, Pankajini Mallick, Dipal Patel, Phenil J. Patel, Darren L. Reid, Manuel Sánchez-Félix · 2020 · The AAPS Journal
15. Phosphorothioate Modification of mRNA Accelerates the Rate of Translation Initiation to Provide More Efficient Protein Synthesis
    Daisuke Kawaguchi, Ayumi Kodama, Naoko Abe, Kei Takebuchi, Fumitaka Hashiya, Fumiaki Tomoike, Kosuke Nakamoto, Yasuaki Kimura, Yoshihiro Shimizu, Hiroshi Abe · 2020 · Angewandte Chemie International Edition
16. Enhancing the therapeutic delivery of oligonucleotides by chemical modification and nanoparticle encapsulation
    Sun, Yating, Zhao, Yarong, Zhao, Xiuting, Lee, Robert J., Teng, Lesheng, Zhou, Chenguang · 2017 · Molecules
17. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy
    Jong Won Lee, Ji‐Won Choi, Yeonho Choi, Kwangmeyung Kim, Yoosoo Yang, Sun Hwa Kim, Hong Yeol Yoon, Ick Chan Kwon · 2022 · Journal of Controlled Release
18. Recent preclinical and clinical advances in oligonucleotide conjugates
    Kevin P. Craig, Marc T. Abrams, Mansoor M. Amiji · 2018 · Expert Opinion on Drug Delivery
19. The challenge of peptide nucleic acid synthesis
    K. P. Nandhini, Danah Al Shaer, Fernando Alberício, Beatriz G. de la Torre · 2023 · Chemical Society Reviews
20. BIOANALYSIS AND BIOTRANSFORMATION OF OLIGONUCLEOTIDE THERAPEUTICS BY LIQUID CHROMATOGRAPHY‐MASS SPECTROMETRY
    James Michael Sutton, Jaeah Kim, Noha M. El Zahar, Michael G. Bartlett · 2020 · Mass Spectrometry Reviews
21. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
    Elias Fattal, François Fay · 2021 · Advanced Drug Delivery Reviews
22. Innovative developments and emerging technologies in RNA therapeutics
    François Halloy, Annabelle Biscans, Katherine E. Bujold, Alexandre J. Debacker, Alyssa C. Hill, Aurélie Lacroix, Olivia Luige, Roger Strömberg, Linda Sundström, Jörg Vogel et al. · 2022 · RNA Biology
23. Recent advances in therapeutic nucleic acids and their analytical methods
    Jadera Talap, J. Y. Zhao, Minzhe Shen, Zihan Song, Hui Zhou, Yu Kang, Lianli Sun, Lushan Yu, Su Zeng, Sheng Cai · 2021 · Journal of Pharmaceutical and Biomedical Analysis
24. Cell type–specific microRNA therapies for myocardial infarction
    Liu, Bohao, Wang, Bryan, Zhang, Xiaokan, Lock, Roberta, Nash, Trevor, Vunjak-Novakovic, Gordana · 2021 · Science Translational Medicine
25. Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
    Thijs Van de Vyver, Stefaan C. De Smedt, Koen Raemdonck · 2021 · Advanced Drug Delivery Reviews
26. Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis
    Xiaoxin Li, Hongzhao Qi, Weigang Cui, Zhibin Wang, Xiuxiu Fu, Tianxiang Li, Huibo Ma, Yanyan Yang, Tao Yu · 2022 · Molecular Therapy
27. Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization
    Colton M. Miller, Edward N. Harris · 2016 · RNA & DISEASE
28. Analysis of therapeutic nucleic acids by capillary electrophoresis
    Wei, Bingchuan, Goyon, Alexandre, Zhang, Kelly · 2022 · Journal of Pharmaceutical and Biomedical Analysis
29. Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington’s disease models
    Faith Conroy, Rachael Miller, Julia F. Alterman, Matthew R. Hassler, Dimas Echeverria, Bruno M.D.C. Godinho, Emily G. Knox, Ellen Sapp, Jaquelyn Sousa, Ken Yamada et al. · 2022 · Nature Communications
30. Biocatalytic Synthesis of Antiviral Nucleosides, Cyclic Dinucleotides, and Oligonucleotide Therapies
    Kyle J. D. Van Giesen, Matthew J. Thompson, Qinglong Meng, Sarah L. Lovelock · 2022 · JACS Au
31. Sulfur modification in natural RNA and therapeutic oligonucleotides
    Ya Ying Zheng, Ying Wu, Thomas J. Begley, Jia Sheng · 2021 · RSC Chemical Biology
32. Dual Mechanisms of Action of Self-Delivering, Anti-HIV-1 FANA Oligonucleotides as a Potential New Approach to HIV Therapy
    Mayumi M. Takahashi, Haitang Li, Jiehua Zhou, Pritsana Chomchan, Veenu Aishwarya, Masad José Damha, John J. Rossi · 2019 · Molecular Therapy — Nucleic Acids
33. Nucleic acid nanotechnology for cancer treatment
    Jun‐O Jin, Gyurin Kim, Juyoung Hwang, Kyung Ho Han, Minseok Kwak, Peter Chang-Whan Lee · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
34. Phosphorothioate nucleic acids for probing metal binding, biosensing and nanotechnology
    Runjhun Saran, Zhicheng Huang, Juewen Liu · 2020 · Coordination Chemistry Reviews
35. The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides
    Miklós Bege, Anikó Borbás · 2022 · Pharmaceuticals
36. Cancer Cell-Selective Membrane Receptor Clustering Driven by VEGF Secretion for In Vivo Therapy
    Shiyi Bi, Wei Chen, Yanyun Fang, Yingfei Wang, Zhang Qing, Hongqian Guo, Huangxian Ju, Ying Liu · 2023 · Journal of the American Chemical Society
37. Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges
    Cristina R. Hofman, David R. Corey · 2023 · Cell chemical biology
38. Quantitative detection of circular RNA and microRNA at point-of-care using droplet digital CRISPR/Cas13a platform
    Ke Wang, Haofan Yin, Shengli Li, Yunzhu Wan, Minmin Xiao, Xiaopeng Yuan, Zhenheng Huang, Yunxin Gao, Jianhua Zhou, Keying Guo et al. · 2024 · Biosensors and Bioelectronics
39. Oligonucleotide-mediated tRNA sequestration enables one-pot sense codon reassignment in vitro
    Zhenling Cui, Yue Wu, Sergey Mureev, Kirill A. Alexandrov · 2018 · Nucleic Acids Research
40. Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy
    Karishma Dhuri, Rutesh Vyas, Leslie Blumenfeld, Rajkumar Verma, Raman Bahal · 2021 · Cells
41. Aptamer-based assembly systems for SARS-CoV-2 detection and therapeutics
    Yuhang Dong, Jingping Wang, Ling Chen, Haonan Chen, Shuangbo Dang, Feng Li · 2024 · Chemical Society Reviews
42. Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and challenges
    Chi Ming Laurence Lau, Yu Yu, Ghodsiehsadat Jahanmir, Ying Chau · 2018 · Advanced Drug Delivery Reviews
43. Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference
    Wei Liu, Naoki Iwamoto, Subramanian Marappan, Khoa Luu, Snehlata Tripathi, Erin Purcell-Estabrook, Juili Dilip Shelke, Himali Shah, Anthony Lamattina, Qianli Pan et al. · 2023 · Nucleic Acids Research
44. Terminal Chemical Modifications of crRNAs Enable Improvement in the Performance of CRISPR-Cas for Point-of-Care Nucleic Acid Detection
    Yunzhu Wan, Shengli Li, Wenfei Xu, Ke Wang, Wenlong Guo, Chongguang Yang, Xuhui Li, Jianhua Zhou, Jiasi Wang · 2024 · Analytical Chemistry
45. Structural Basis of Duplex Thermodynamic Stability and Enhanced Nuclease Resistance of 5′-C-Methyl Pyrimidine-Modified Oligonucleotides
    Alexander V. Kel’in, Ivan Zlatev, Joel M. Harp, Muthusamy Jayaraman, Anna Bisbe, Jonathan O′Shea, Nate Taneja, Rajar M. Manoharan, Saeed I. Khan, Klaus Charissé et al. · 2016 · The Journal of Organic Chemistry
46. Amide linkages mimic phosphates in RNA interactions with proteins and are well tolerated in the guide strand of short interfering RNAs
    Daniel Mutisya, Travis Hardcastle, Samwel K. Cheruiyot, Pradeep S. Pallan, Scott D. Kennedy, Martin Egli, Melissa L. Kelley, Anja van Brabant Smith, Eriks Rozners · 2017 · Nucleic Acids Research
47. Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases
    Yoshitsugu Aoki, Matthew J. A. Wood · 2021 · Journal of Neuromuscular Diseases
48. Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides
    Wang, Dali, Wang, Qiwei, Wang, Yuyan, Chen, Peiru, Lu, Xueguang, Jia, Fei, Sun, Yehui, Sun, Tingyu, Zhang, Lei, Che, Fangyuan et al. · 2022 · Proceedings of the National Academy of Sciences
49. Chemically Modified mocRNAs for Highly Efficient Protein Expression in Mammalian Cells
    Abhishek J. Aditham, Hailing Shi, Jianting Guo, Hu Zeng, Yiming Zhou, Sarah D. Wade, Jiahao Huang, Jia Liu B, Xiao Wang · 2022 · ACS Chemical Biology
50. Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review
    Hamid Motamedi, Marzie Mahdizade Ari, Amirhooshang Alvandi, Ramin Abiri · 2024 · Frontiers in Microbiology
51. Non canonical genetic material
    Elena Eremeeva, Piet A. Herdewijn · 2018 · Current Opinion in Biotechnology
52. Control of gene doping in human and horse sports
    Teruaki Tozaki, Natasha Anne Hamilton · 2021 · Gene Therapy
53. Clinical Pharmacokinetics of Approved RNA Therapeutics
    Seong Jun Jo, Soon Uk Chae, Chae Bin Lee, Soo Kyung Bae · 2023 · International Journal of Molecular Sciences
54. Nanotechnology-enabled gene delivery for cancer and other genetic diseases
    Tong Jiang, Karina Marie Gonzalez, Leyla Estrella Cordova, Jianqin Lu · 2023 · Expert Opinion on Drug Delivery
55. Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy
    Socheata Ly, Dimas Echeverria, Jacquelyn Sousa, Anastasia Khvorova · 2020 · Molecular Therapy — Nucleic Acids
56. Allele-Selective Inhibition of Mutant Huntingtin with 2-Thio- and C5- Triazolylphenyl-Deoxythymidine-Modified Antisense Oligonucleotides
    Michael E. Østergaard, Pawan Kumar, Josh G. Nichols, Andrew T. Watt, Pawan K. Sharma, Poul Nielsen, Punit P. Seth · 2015 · Nucleic Acid Therapeutics
57. An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides
    Ysobel R. Baker, Cameron Thorpe, Jinfeng Chen, Laura M. Poller, Lina Cox, Pawan Kumar, Wooi Fang Lim, Lillian Lie, Graham McClorey, Sven Epple et al. · 2022 · Nature Communications
58. Analytical techniques for characterizing diastereomers of phosphorothioated oligonucleotides
    Tao Chen, Shijia Tang, Yige Fu, José G. Napolitano, Kelly Zhang · 2022 · Journal of Chromatography A
59. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking
    Priyanka Mangla, Quentin Vicentini, Annabelle Biscans · 2023 · Cells
60. Tissue pharmacokinetics of antisense oligonucleotides
    Erica Bäckström, Alessandro Bonetti, Per Johnsson, Stefan Öhlin, Anders Dahlén, Patrik Urban Andersson, Shalini Andersson, Peter Gennemark · 2024 · Molecular Therapy — Nucleic Acids
61. Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide
    Umme Sabrina Haque, Toshifumi Yokota · 2023 · Cells
62. Extracellular Vesicles: A New Star for Gene Drug Delivery
    Man Sun, Huan Zhang, Jiayi Liu, Jiayi Chen, Yaxin Cui, Simiao Wang, Xiangyu Zhang, Zhaogang Yang · 2024 · International Journal of Nanomedicine
63. Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease
    Andrea Marco Caddeo, Stefano Romeo · 2024 · Clinical and Molecular Hepatology
64. DNA Analogues Modified at the Nonlinking Positions of Phosphorus
    Pawan Kumar, Marvin H. Caruthers · 2020 · Accounts of Chemical Research
65. An aptamer-based depot system for sustained release of small molecule therapeutics
    Dali Wang, Yang Li, Xiaoran Deng, Matthew Torre, Zipei Zhang, Xiyu Li, Wei Zhang, Kathleen Cullion, Daniel S. Kohane, Christopher Bertero Weldon · 2023 · Nature Communications
66. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
    Fengjiao Yao, Yacong An, Xundou Li, Zhaoyi Li, Jinhong Duan, Xian‐Da Yang · 2020 · International Journal of Nanomedicine
67. Detailed cellular assessment of albumin-bound oligonucleotides: Increased stability and lower non-specific cell uptake
    Aurélie Lacroix, Hassan H. Fakih, Hanadi F. Sleiman · 2020 · Journal of Controlled Release
68. Quantification of Antisense Oligonucleotides by Splint Ligation and Quantitative Polymerase Chain Reaction
    Minwook Shin, Pranathi Meda Krishnamurthy, Gitali Devi, Jonathan K. Watts · 2021 · Nucleic Acid Therapeutics
69. Chemical modification patterns for microRNA therapeutic mimics: a structure-activity relationship (SAR) case-study on miR-200c
    Marion Garreau, Julie Weidner, Russell S. Hamilton, Ewa Kołosionek, Naoko Toki, Kathrin Stavenhagen, Clément Paris, Alessandro Bonetti, Werngard Czechtizky, Felix A. Gnerlich et al. · 2024 · Nucleic Acids Research
70. Nucleic acid binding by SAMHD1 contributes to the antiretroviral activity and is enhanced by the GpsN modification
    Corey H. Yu, Akash Bhattacharya, Mirjana Persaud, Alexander B. Taylor, Zhonghua Wang, Ángel Bulnes‐Ramos, Joella Xu, Anastasia Selyutina, Alicia Martínez‐López, Kristin E. Cano et al. · 2021 · Nature Communications
71. Ion-pair reversed-phase and hydrophilic interaction chromatography methods for analysis of phosphorothioate oligonucleotides
    Martin Gilár, Brooke M. Koshel, Robert E. Birdsall · 2023 · Journal of Chromatography A
72. Antisense oligonucleotides and their applications in rare neurological diseases
    Simon McDowall, May Thandar Aung-Htut, Steve Donald Wilton, Dunhui Li · 2024 · Frontiers in Neuroscience
73. Scalable modulation of CRISPR‒Cas enzyme activity using photocleavable phosphorothioate DNA
    Menglu Hu, Bingni Zhang, Yuanyue Shan, Feng Cao, Yihui Wang, Weiwei Qi, Xue Wang, Yuting Shen, Xinyi Guo, Mengmeng Zhang et al. · 2025 · Nature Communications
74. Chemical synthesis of stimuli-responsive guide RNA for conditional control of CRISPR-Cas9 gene editing
    Chunmei Gu, Lu Xiao, Jiachen Shang, Xiao Xu, Luo He, Yu Xiang · 2021 · Chemical Science
75. Investigations on the molecular mode of action of the novel immunostimulator ZelNate: Activation of the cGAS-STING pathway in mammalian cells
    Thomas Ilg · 2017 · Molecular Immunology
76. Antisense Oligonucleotides, A Novel Developing Targeting Therapy
    Sara Karaki, Clément Paris, Palma Rocchi · 2019 · IntechOpen eBooks
77. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9
    Christopher L. Barkau, Daniel O’Reilly, Kushal J. Rohilla, Masad José Damha, Keith T. Gagnon · 2019 · Nucleic Acid Therapeutics
78. RNA modifications can affect RNase H1-mediated PS-ASO activity
    Katelyn A. Doxtader, Xue‐hai Liang, Lingdi Zhang, Stanley T. Crooke · 2022 · Molecular Therapy — Nucleic Acids
79. Brain delivering RNA-based therapeutic strategies by targeting mTOR pathway for axon regeneration after central nervous system injury
    Ming-Xi Li#, Jingwen Weng, Eric S. Ho, Shing Fung Chow, Chi Kwan Tsang · 2022 · Neural Regeneration Research
80. Therapeutic antisense oligonucleotides for movement disorders
    Epaminondas Doxakis · 2020 · Medicinal Research Reviews
81. Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules
    Manuel Hawner, C. Ducho · 2020 · Molecules
82. Bridged Nucleic Acids Reloaded
    Alfonso Soler‐Bistué, Ángeles Zorreguieta, Marcelo E. Tolmasky · 2019 · Molecules
83. Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles
    Brian J. Jurgielewicz, Steven L. Stice, Yao Yao · 2021 · Aging and Disease
84. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities
    Wilson Huang, Doru Paul, George A. Călin, Recep Bayraktar · 2023 · Cells
85. Nanostructured DNA for the delivery of therapeutic agents
    Makiya Nishikawa, Mengmeng Tan, Wenqing Liao, Kosuke Kusamori · 2019 · Advanced Drug Delivery Reviews
86. Antisense Oligonucleotides as Potential Therapeutics for Type 2 Diabetes
    Suxiang Chen, Nabayet Sbuh, Rakesh Naduvile Veedu · 2020 · Nucleic Acid Therapeutics
87. Structural Insights into the Interaction of Clinically Relevant Phosphorothioate mRNA Cap Analogs with Translation Initiation Factor 4E Reveal Stabilization via Electrostatic Thio-Effect
    Marcin Warmiński, Joanna Kowalska, Elżbieta Nowak, Dorota Kubacka, Ryan W. Tibble, Renata Kasprzyk, Pawel J. Sikorski, John D. Gross, Marcin Nowotny, Jacek Jemielity · 2021 · ACS Chemical Biology
88. Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates
    Lars O. G. Weidolf, Anders Björkbom, Anders Dahlén, Marie Elebring, Peter Gennemark, Mikko Hölttä, David L. I. Janzén, Xueqing Li, Shalini Andersson · 2021 · Drug Discovery Today
89. Metal-Free S -Arylation of Phosphorothioate Diesters and Related Compounds with Diaryliodonium Salts
    Sudeep Sarkar, Marcin Kałek · 2023 · Organic Letters
90. Recent advances in peptide-based therapeutic strategies for breast cancer treatment
    Ling Li, Gregory Joseph Duns, Wubliker Dessie, Zhenmin Cao, Xiaoyuan Ji, Xiaofang Luo · 2023 · Frontiers in Pharmacology
91. Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model
    Lucía Echevarría, Philippine Aupy, Karima Relizani, Thomas Bestetti, Graziella Griffith, Florence Blandel, Marek Komisarski, Adrian Haeberli, Fédor Svinartchouk, Luis Garcı́a et al. · 2019 · Nucleic Acid Therapeutics
92. The MOE Modification of RNA: Origins and Widescale Impact on the Oligonucleotide Therapeutics Field
    Alyssa C. Hill, Jonathan Hall · 2023 · Helvetica Chimica Acta
93. Technologies for Targeted RNA Degradation and Induced RNA Decay
    Sigitas Mikutis, Gonçalo J. L. Bernardes · 2024 · Chemical Reviews
94. Impact of Phosphorothioate Chirality on Double‐Stranded siRNAs: A Systematic Evaluation of Stereopure siRNA Designs
    Sukumar Sakamuri, Laxman Eltepu, Dingguo Liu, Son N. Lam, Bryan R. Meade, Bin Liu, Giuseppe Dello Iacono, Ayman Kabakibi, Lena Luukkonen, Tom A. Leedom et al. · 2019 · ChemBioChem
95. Preventing acute neurotoxicity of CNS therapeutic oligonucleotides with the addition of Ca2+ and Mg2+ in the formulation
    Rachael Miller, Joseph D. Paquette, Alexandra Barker, Ellen Sapp, Nicholas McHugh, Brianna M. Bramato, Nozomi Yamada, Julia F. Alterman, Dimas Echeverria, Ken Yamada et al. · 2024 · Molecular Therapy — Nucleic Acids
96. Solid-Phase Synthesis of Phosphorothioate Oligonucleotides Using Sulfurization Byproducts for in Situ Capping
    Jimin Yang, Jessica A. Stolee, Hong Jiang, Xiao Li, William F. Kiesman, Firoz D. Antia, Yannick A. Fillon, Austen Ng, Xianglin Shi · 2018 · The Journal of Organic Chemistry
97. Stereochemistry Enhances Potency, Efficacy, and Durability of Malat1 Antisense Oligonucleotides In Vitro and In Vivo in Multiple Species
    Michael Byrne, Vinod Vathipadiekal, Luciano H. Apponi, Naoki Iwamoto, Kandasamy Pachamuthu, Kenneth A. Longo, Fangjun Liu, Richard J. Looby, Lauren Norwood, Anee Shah et al. · 2021 · Translational Vision Science & Technology
98. Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization
    Suzan M. Hammond, Olga V. Sergeeva, Pavel Melnikov, Larissa Goli, Jessica Stoodley, Timofei S. Zatsepin, Dmitry A. Stetsenko, Matthew J. A. Wood · 2021 · Nucleic Acid Therapeutics
99. Evaluation of Phosphorus and Non-Phosphorus Neutral Oligonucleotide Backbones for Enhancing Therapeutic Index of Gapmer Antisense Oligonucleotides
    Guillermo Vasquez, Michael T. Migawa, W. Brad Wan, Audrey Low, Michael Tanowitz, Eric E. Swayze, Punit P. Seth · 2021 · Nucleic Acid Therapeutics
100. Splicing mutations in the CFTR gene as therapeutic targets
     Karine Delétang, Magali Taulan‐Cadars · 2022 · Gene Therapy